ESSA Pharma Inc. Common Stock (EPIX)
ESSA Pharma Inc. (EPIX) is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for prostate cancer. The company specializes in the research and development of novel drugs targeting androgen receptor signaling pathways to treat advanced prostate cancer, including castration-resistant prostate cancer. Founded with a focus on addressing unmet medical needs, ESSA Pharma aims to advance therapies that can overcome resistance to existing treatments.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 22, 2025 | $1.69 | 2025-08-25 | 2025-08-19 |
Dividends Summary
- ESSA Pharma Inc. Common Stock has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 63 days ago, on August 22, 2025
- The highest dividend payed out to investors during this period was $1.69 per share
- The average dividend paid during this period was $1.69 per share.
Company News
ESSA Pharma Inc. announced a $80 million return of capital distribution to shareholders as part of its discontinuance and winding-up transaction with XenoTherapeutics, with distribution scheduled for August 22, 2025.
Law firm Monteverde & Associates is investigating the proposed sale of ESSA Pharma to Xeno Acquisition Corp, examining the fairness of the transaction terms for shareholders.
Check these strategies out for buying penny stocks right no The post 3 Beginner Penny Stocks Trading Mistakes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.